Menu

All News

6942 Results

The drug industry has long paid influential doctors to speak to peers as a way of building word-of-mouth marketing. But such practices can cross the line, legal experts say, when doctors promote uses of the drug that are not approved by the Food and Drug Administration, and when speaking fees are paid in exchange for the doctors’ prescribing behavior. Eric Campbell, professor of medicine at Massachusetts General Hospital, is quoted.

Antibody drug helps revive immune system attack on cancer

Many older people silently harbor a blood “pre-cancer”—a gene mutation acquired during their lifetime that could start them on the path to leukemia, lymphoma or other blood disease, scientists have discovered. The discovery was made by two international research teams working independently, decoding the DNA of about 30,000 people. Steven McCarroll, assistant professor of genetics, is senior author of one of the papers. Benjamin Ebert, associate professor of medicine at Brigham and Women’s Hospital, is senior author of the other paper.

Harvard Medical School student Carlos Estrada Alamo authored this opinion piece about immigration reform.

James (Jim) O’Connell, assistant professor of medicine at Massachusetts General Hospital, participated in an interview about Massachusetts governor-elect Charlie Baker’s enthusiasm for tackling the epidemic of opiate addiction as soon as he takes office in January and his past advocacy for Boston’s homeless.

John Halamka, professor of medicine and chief information officer of Beth Israel Deaconess Medical Center, is profiled.

President Obama’s executive order preventing the deportation of up to 5 million undocumented immigrants won’t preclude all of them from getting affordable health coverage. But it remains to be seen just how many will be presented with that option. Julia Koehler, assistant professor of pediatrics at Boston Children’s Hospital, is quoted.

Advanced life support ambulances for out-of-hospital cardiac arrest cost lives

Cultivating tomorrow’s researchers benefits all

Harvard Pilgrim Health Care and Massachusetts General Hospital researchers say that health care reform hasn’t affected the health of those with chronic diseases. Tomasz P. Stryjewski, clinical fellow in ophthalmology at Massachusetts Eye and Ear, is the lead author of the study. J. Frank Wharam, assistant professor of population medicine, is the senior author.

Emergency treatments delivered in ambulances that offer “Advanced Life Support” for cardiac arrest may be linked to more death, comas and brain damage than those providing “Basic Life Support.” Prachi Sanghavi, a PhD student in the Harvard Program in Health Policy, is lead author of the study.

Studies show that older African Americans are almost twice as likely as whites to develop Alzheimer’s disease for genetic, biological and socioeconomic reasons. Yet relatively few African Americans want to talk about Alzheimer’s, which is the leading cause of dementia. For historical reasons, even fewer want to participate in clinical research trials that could deliver benefits to themselves and future generations. Reisa A. Sperling, professor of neurology at Brigham and Women’s Hospital, is quoted. Sperling is the principal investigator of a study involving 60 sites in the United States, Canada and Australia attempting to learn whether regular transfusions of an antibody will stop the cascading series of events that lead to memory loss, cognitive impairment and, eventually, death.